FDA Approves JUVÉDERM VOLBELLA XC for Undereye Hollows
Allergan Aesthetics, an AbbVie company, announces the FDA approval of JUVÉDERM VOLBELLA XC for improvement of infraorbital hollows in adults over the age of 21.
Allergan Aesthetics, an AbbVie company, announces the FDA approval of JUVÉDERM VOLBELLA XC for improvement of infraorbital hollows in adults over the age of 21.
Anil Shah, MD, FACS, a Chicago-based facial plastic surgeon, shares insights on the evolution of hair restoration, emerging treatments, and advice for patients.